Blanka Andersson
Impact in
- Neurology top 2%
- Myasthenia Gravis and Thymoma
- Peripheral Neuropathies and Disorders
- Autoimmune Neurological Disorders and Treatments
-
- Complement system in diseases
Papers in
-
- Tuberculosis Research and Epidemiology 7
-
- Myasthenia Gravis and Thymoma 1
- Co-authors
- Robert Blomgran (2 shared papers)Johanna Raffetseder (2 shared papers)Anna‐Maria Andersson (1 shared paper)Marie Larsson (1 shared paper)Mulugeta Melkie Zegeye (1 shared paper)Liza U. Ljungberg (1 shared paper)Allan Sirsjö (1 shared paper)Maria Lerm (6 shared papers)
- Journals
- Tuberculosis (2 papers)PLoS ONE (2 papers)Scientific Reports (2 papers)Cells (1 paper)The Lancet Neurology (1 paper)
- Partner nations
- Sweden
In The Last Decade
Blanka Andersson
10 papers receiving 765 citations
Blanka Andersson's Hit Papers
Peers
Comparison fields: 5 of 58
- Neurology 506
- Immunology 87
- Infectious Diseases 76
- Pathology and Forensic Medicine 27
- Neurology 8
Countries citing papers authored by Blanka Andersson
This map shows the geographic impact of Blanka Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blanka Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blanka Andersson more than expected).
Fields of papers citing papers by Blanka Andersson
This network shows the impact of papers produced by Blanka Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blanka Andersson. The network helps show where Blanka Andersson may publish in the future.
Co-authors
The 25 scholars most cited alongside Blanka Andersson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study Hit paper breakdown → | 2017 | 632 |
| 2 | 2016 | 65 | |
| 3 | 2020 | 39 | |
| 4 | 2014 | 18 | |
| 5 | 2017 | 12 | |
| 6 | 2021 | 7 | |
| 7 | 2022 | 7 | |
| 8 | 2024 | 6 | |
| 9 | 2020 | 4 | |
| 10 | 2011 | 1 |
About Blanka Andersson
Blanka Andersson is a scholar working on Infectious Diseases, Neurology, Molecular Biology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 10 papers that have together received 791 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (7 papers), Bacillus and Francisella bacterial research (1 paper), Myasthenia Gravis and Thymoma (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Neurology (506 citations), Immunology (87 citations), Infectious Diseases (76 citations), Pathology and Forensic Medicine (27 citations) and Neurology (8 citations). Blanka Andersson has collaborated with scholars based in Sweden. Frequent co-authors include Robert Blomgran, Johanna Raffetseder, Anna‐Maria Andersson, Marie Larsson, Mulugeta Melkie Zegeye, Liza U. Ljungberg, Allan Sirsjö, Maria Lerm, Thomas Schön and Olle I. Stendahl. Their work appears in journals such as Tuberculosis, PLoS ONE, Scientific Reports, Cells and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.